HIGHLIGHTS FROM THE MN HIV SURVEILLANCE REPORT Minnesota Department of Health HIV/AIDS Surveillance System
|
|
|
- Iris Richardson
- 5 years ago
- Views:
Transcription
1 HIGHLIGHTS FROM THE MN HIV SURVEILLANCE REPORT 2013 Minnesota Department of Health HIV/AIDS Surveillance System
2
3 Estimated Number of Persons Living with HIV/AIDS in Minnesota As of December 31, 2013, 7,723* persons are assumed alive and living in Minnesota with HIV/AIDS 4,095 living with HIV infection (non-aids) 3,628 living with AIDS * This number includes persons who reported Minnesota as their current state of residence, regardless of residence at time of diagnosis. Includes state prisoners and refugees arriving through the HIV+ Refugee Resettlement Program, as well as HIV+ refugee/immigrants arriving through other programs.
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36 Minnesota HIV Treatment Cascade
37 Percentage of persons diagnosed with HIV engaged in selected stages of the continuum of care Minnesota
38 Conclusions There were 301 new HIV diagnoses reported in Minnesota in 2013, a decrease of 4% from 2012 Great disparities in HIV diagnoses persist among populations of color and American Indians living in Minnesota Male-to-male sex remains the leading risk factor for acquiring HIV/AIDS in Minnesota New HIV diagnoses remain concentrated in the Twin Cities seven-county metro area (82% of new diagnoses in 2013) Foreign-born persons made up nearly 1 in 5 of new HIV diagnoses in 2013, and progress from HIV to AIDS more quickly than U.S. born persons living with HIV in Minnesota
39 Thank You! For more information, please contact: Jessica Brehmer, HIV/AIDS Epidemiologist (651)
40 The place where two discriminations exist is a dangerous place to live. - Richard (Anguksuar) LaFortune Using Public Health Programming to Mitigate Disease and Death from Opiate Drug Use Sarah Gordon, MPH, NREMT-B
41 The issue is not simple. disease, heroin, death, stigma, addiction, war on drugs, healthcare access, harm reduction Injection drug use is a well-known route of transmission of blood borne infections, particularly HIV and hepatitis B and C. Use of illicit drugs is associated with increased rates of TB and STDs. Recommended approaches, immunizations and screening, can protect the health of a person who uses drugs through medical interventions, while evidence-based behavioral interventions help prevent sexual and injection transmission by addressing risky behaviors.
42 Increase in Opiate Use In Minnesota Maps show grams per 10,000 people of prescriptions for painkiller opiates (such as oxycodone, hydrocodone, codeine, morphine) in each three-digit ZIP code area. Source: Drug Enforcement Administration. TwinCities.com DATA 2014
43 Heroin Influx in Midwest Courtesy Carol Falkowski Drug Abuse Trends June 2013, Drug Abuse Dialogues
44 Twin Cities has the cheapest and strongest heroin in the country, officials say By Aaron Rupar Thu., Jun at 1:04 PM At the newser, a doctor said there were four heroin-related deaths reported in Hennepin County in Last year, that number shot up to 37, and Hennepin County Sheriff Rich Stanek said the county is on pace to set a new record this year. Stanek also said the heroin he's seeing these days in Hennepin County is the cheapest and strongest in the country, a combination he characterized as particularly deadly. His comments reiterated what law enforcement officials said at a similar news conference last year. Then, they referenced an analysis showing that some heroin found on Twin Cities' streets was up to 93 percent pure, whereas typical American street heroin has a purity of about 35 percent. "A heroin user in the Twin Cities has a greater chance of accidental overdose because the purity of that heroin is so high," Stanek said during that news conference. At today's newser, officials pointed out the role prescription drugs play as a gateway to heroin. According to the Star Tribune, data showed that heroin and prescription drug abuse in the Twin Cities reached an all-time high last year. The two accounted for 21 percent of all addiction treatments in the state, with only alcohol abuse accounting for a higher share.
45 Courtesy Carol Falkowski, Drug Abuse Trends June 2012, Drug Abuse Dialogues
46 Heroin vs. other opiate treatment admission Slide courtesy Rick Moldenhauer, DHS Source: DAANES, PMQI, MN DHS 2014
47
48 CDC Declares an Epidemic In 2010, overdose death become the leading cause of injury death in the US
49
50 Local Impact Hennepin/Ramsey County Drug Deaths Deaths Opiates Cocaine Methamphetamine Hennepin County Medical Examiner and Ramsey County Medical Examiner, 2013
51 What makes opioid users at particular risk of overdose fatality? Among patients receiving opioid prescriptions for pain, higher opioid doses were associated with increased risk of opioid overdose death. Bohnert, et al Poly-drug use Bohnert, et al Substance use disorders and co-occuring mental health disorders Hall, et. al., 2008 Purity! Mexican heroin purity in Minneapolis highest in country and sold at lowest cost DEA Domestic Monitoring Program 2009
52 What makes opioid users at particular risk of overdose fatality? (continued) Fear! Fear of police response was the most commonly cited reason for not calling or delaying before calling for help Efforts to equip drug users to manage overdoses effectively, including training in first aid and the provision of naloxone, and the reduction of police involvement at overdose events may have a substantial impact on overdose-related morbidity and mortality. Tracy, et al. Drug and Alcohol Dependence. 09/2005
53 Non-fatal overdose in injection drug users Reality of drug use. Lifetime prevalence ~ 40% Of these ~ 70% reversed by naloxone Lifetime witnesses ~ 90% Fatal 1-3 hour window for medical intervention Sackoff et al. Ann Int Med, 2006; Ermak et al. 2009
54 The other reality of drug use.
55 Public Health Programming to Prevent Disease
56 Role of Needle Exchange in HIV and Hepatitis C Prevention Efforts The public health approach to disease prevention is to reduce risk of infection whether individual stops the risk behavior or not, which thereby protects the health of the community
57 Syringe Exchange is low-threshold entry point for drug users into prevention services and treatment Exchange participants 5x more likely to enter drug treatment than nonparticipants 67% of all exchange programs offer HCV testing and 87% offer HIV testing and linkage to care Since implementation of exchange programs in the late 80s, HIV rates in injection drug users decreased overall by 80 %
58 Syringe Exchange Promotes Public Post implementation of syringe exchange programs reduce number of syringes found in public areas. 50% drop in Baltimore 2/3 reduction in Portland, OR Safety Implementation of syringe exchange programs reduces needle-stick injuries to police. 2/3 injury reduction for Connecticut law enforcement 66% reduction for Macon County, NC law enforcement
59 Testing is Prevention! 2 good reasons to get tested for HIV and HCV If you have HIV and/or HCV, you can get treatment and healthy lifestyle education that may help you live a longer, healthier life. If you do not have HIV or HCV, you can learn how to stay that way. Studies show persons who are aware of their status decrease behaviors that help transmit infection
60 911 Good Samaritan Laws Purpose: increase overdose survival rates by encouraging overdose witnesses to seek medical help through limited immunity from arrest and prosecution for minor drug and alcohol violation Good Sam laws do not protect from arrest for other offenses, such as selling or trafficking, or driving while drugged 15 states and District of Columbia have Good Sam policies New Mexico, California, Colorado, New Jersey, New York, Rhode Island, Illinois, Florida, Massachusetts, Connecticut, North Carolina, Vermont, Delaware, Georgia, and Washington
61 Broadening Naloxone Access Broader naloxone access policies puts overdose antidote in the hands of witnesses, first responders, community prevention programs High affinity opioid receptor antagonist Rapidly absorbed via IV, IM, SC, IN routes Half-life ~ 40 minutes Non-abusable Adverse effect withdrawal Shelf-life 3 years
62 What is the Overdose Antidote?
63 An Opiate Antagonist
64
65 What s coming in MN? Steve's Law (HF2307 / SF1900) itannaloxonecampaign
66 Thank you!! For more information, please contact: Sarah Gordon, MPH Coordinator, HIV Testing and Syringe Services Programs Minnesota Department of Health
67 Hepatitis A, B & C in Minnesota, 2013 Minnesota Department of Health Hepatitis Surveillance System
68 Minnesota Hepatitis Surveillance System Hepatitis B reportable since 1987 Hepatitis C reportable since 1998 Passive data collection
69 Viral Hepatitis Overview
70 Introduction Data in this presentation are current through 2013 Definitions: Acute case: Infected within the last six months Symptomatic OR negative test in six months before diagnosis Chronic case: Infected for over six months Asymptomatic or symptomatic Resolved cases: No evidence of current infection Evidence of past infection Data Source: Minnesota Viral Hepatitis Surveillance System
71 Data limitations The slides rely on data from HCV and HBV cases diagnosed through 2013 and reported to the Minnesota Department of Health (MDH) Hepatitis Surveillance System. Some limitations of surveillance data: Data do not include hepatitis-infected persons who have not been tested Data do not include persons whose positive test results have not been reported to the MDH Persons are assumed to be alive unless the MDH has knowledge of their death. Persons whose most recently reported state of residence was Minnesota are assumed to be currently residing in Minnesota unless the MDH has knowledge of their relocation. Data Source: Minnesota Viral Hepatitis Surveillance System
72 Acute Viral Hepatitis Acute case: Infected within the last six months Symptomatic OR negative test within 6 months before diagnosis
73 Reported rate per 100,000 population of acute viral hepatitis United States, Data Source: Viral Hepatitis Statistics & Surveillance at
74 Number of Acute* Cases per year Minnesota, Data Source: MN Viral Hepatitis Surveillance System *Acute cases include seroconverters for all years for HBV and HCV
75 Chronic Viral Hepatitis
76 Overview of Chronic HBV in MN Chronic case: Infected for over six months Includes cases with no evidence of recent infection Asymptomatic or symptomatic
77 Reported Number of Persons with Chronic HBV in MN As of December 31, 2013, 21,585* persons are assumed alive and living in MN with chronic HBV *Includes persons with unknown city of residence Note: Includes all chronic, and probable chronic cases. Data Source: MN Viral Hepatitis Surveillance System
78 Persons Living with HBV in MN by Current Residence, 2013 Total number with residence information = 21,242 (343 missing residence information) Data Source: MN Viral Hepatitis Surveillance System Metro = Seven-county metro area including Anoka, Carver, Dakota, Hennepin, Ramsey, Scott, and Washington counties. Greater MN = All other Minnesota counties, outside the seven-county metro area.
79 Persons with Chronic HBV in MN by Age, 2013 Median Age: 43 Data Source: MN Viral Hepatitis Surveillance System
80 Data Source: MN Viral Hepatitis Surveillance System Chronic HBV in MN by Gender, 2013
81 Persons Living with Chronic HBV in Minnesota by Race, 2013 Other 1% Unknown 16% Amer Ind 0% Asian 44% Hispanic 1% White 11% Data Source: MN Viral Hepatitis Surveillance System Afr Amer 27% Persons with unknown race=3,365 Afr Amer = African American /Black Asian=Asian or Pacific Islander Amer Ind = American Indian Other = Multi-racial persons or persons with other race
82 Persons Living with Chronic HBV in Minnesota by Race rates (per 100,000 persons*), 2013 Data Source: MN Viral Hepatitis Surveillance System *Rates calculated using 2010 U.S. Census data Excludes 3,396 cases with multiple races and unknown race
83 Overview of HCV in Minnesota A hepatitis C case is defined as current or past infection with hepatitis C and includes: Acute cases: Infected within the last six months Symptomatic Chronic cases: Infected for over six months Resolved cases: No evidence of current infection Evidence of past infection
84 Reported Number of Persons Living with HCV in MN As of December 31, 2013, 40,943* persons are assumed alive and living in MN with HCV Data Source: MN Viral Hepatitis Surveillance System *Includes persons with unknown city of residence Note: Includes all acute, chronic, probable chronic, and resolved cases.
85 HCV Infected Persons Identified through Passive Surveillance in MN through 2013 N=84,863** Estimated unidentified HCV infected persons 40,943 43,920 HCV infected persons* identified through passive surveillance Data Source: MN Viral Hepatitis Surveillance System *Includes all acute, chronic, probable chronic, and resolved cases. **
86 Persons Living with HCV in MN by Current Residence, 2013 Total number with residence information= 40,033 (1,271 missing residence information) Suburban = Seven-county metro area including Anoka, Carver, Dakota, Hennepin (except Minneapolis), Ramsey (except St. Paul), Scott, and Washington counties including those in Hennepin County or Ramsey County with unknown city. Greater MN = All other Minnesota counties, outside the seven-county metro area. Data Source: MN Viral Hepatitis Surveillance System
87 Persons Living with HCV in MN by Age, 2013 Median Age: 56 Data Source: MN Viral Hepatitis Surveillance System
88 Persons Living with HCV in MN by Gender*, 2013 *Includes anonymous methadone patients Data Source: MN Viral Hepatitis Surveillance System
89 Persons Living with Chronic HCV in Minnesota by Race, 2013 Afr Amer = African American /Black Asian=Asian or Pacific Islander Amer Ind = American Indian Other = Multi-racial persons or persons with other race
90 Persons Living with HCV in Minnesota rates (per 100,000 persons*), 2013 Data Source: MN Viral Hepatitis Surveillance System *Rates calculated using 2010 U.S. Census data Excludes persons with multiple races or unknown race
91 Hepatitis C in Populations of Interest
92 Hepatitis C in young adults under age 30
93 Reported Number of Persons <30 Living with HCV in MN As of December 31, 2013, 1,764* persons under the age of 30 are assumed alive and living in MN with HCV *Includes persons with unknown city of residence Note: Includes all acute, chronic, probable chronic, and resolved cases. Data Source: Minnesota Viral Hepatitis Surveillance System
94 Persons <30 Living with HCV in MN by Current Residence, 2013 MN Overall MN Age Under 30 years Total number with residence information= 40,333 Total number with residence information= 1,745 Suburban = Seven-county metro area including Anoka, Carver, Dakota, Hennepin (except Minneapolis), Ramsey (except St. Paul), Scott, and Washington counties including those in Hennepin County or Ramsey County with unknown city. Greater MN = All other Minnesota counties, outside the seven-county metro area. Data Source: Minnesota Viral Hepatitis Surveillance System
95 Persons <30 Living with HCV in MN by Gender*, 2013 MN Overall MN Age Under 30 years *Includes anonymous methadone patients Data Source: Minnesota Viral Hepatitis Surveillance System
96 Persons <30 Living with HCV in MN by Race, 2013 MN Overall MN Age Under 30 years Suburban = Seven-county metro area including Anoka, Carver, Dakota, Hennepin (except Minneapolis), Ramsey (except St. Paul), Scott, and Washington counties including those in Hennepin County or Ramsey County with unknown city. Greater MN = All other Minnesota counties, outside the seven-county metro area. Data Source: Minnesota Viral Hepatitis Surveillance System
97 Hepatitis C in American Indians
98 Reported Number of American Indian Persons Living with HCV in MN As of December 31, 2013, 2,073* persons who identify as American Indian are assumed alive and living in MN with HCV *Includes persons with unknown city of residence Note: Includes all acute, chronic, probable chronic, and resolved cases. Data Source: Minnesota Viral Hepatitis Surveillance System
99 American Indian Persons Living with HCV in MN by Current Residence, 2013 MN Overall MN American Indian Total number with residence information= 40,333 Total number with residence information= 2,058 Suburban = Seven-county metro area including Anoka, Carver, Dakota, Hennepin (except Minneapolis), Ramsey (except St. Paul), Scott, and Washington counties including those in Hennepin County or Ramsey County with unknown city. Greater MN = All other Minnesota counties, outside the seven-county metro area. Data Source: Minnesota Viral Hepatitis Surveillance System
100 American Indian Persons Living with HCV in MN by Age, 2013 Median Age: 51 Data Source: Minnesota Viral Hepatitis Surveillance System
101 Persons Living HCV in MN by Gender*, 2013 MN Overall MN American Indian *Includes anonymous methadone patients Data Source: Minnesota Viral Hepatitis Surveillance System
102 Hepatitis C Treatment
103 Hepatitis C Treatment Changes Direct acting antiviral agents approved in the U.S. Improved rates of sustained virologic response Rapidly changing recommendations hcvguidelines.org
104 Thank you! For more information please contact: Kristin Sweet
105 QUESTIONS? Jessica Brehmer, MPH, HIV Epidemiologist, MDH , Sarah Gordon, MPH, Coordinator, HIV Testing and Syringe Services Programs, MDH , Kristin Sweet, MPH, Hepatitis Epidemiologist, MDH ,
STD, HIV and Hepatitis C 2017 Data Release. April 24,2018
STD, HIV and Hepatitis C 2017 Data Release April 24,2018 Acronyms MDH = Minnesota Department of Health STD = Sexually transmitted disease MSM = Men who have sex with men HCV = Hepatitis C virus HBV =Hepatitis
HIV Incidence Report, Sexually Transmitted Diseases, HIV and Tuberculosis Section, Epidemiology and Surveillance Unit
HIV Incidence Report, 2017 Sexually Transmitted Diseases, HIV and Tuberculosis Section, Epidemiology and Surveillance Unit Introduction (I) These two introduction slides provide a general context for the
HIV/AIDS Perinatal Surveillance Minnesota Department of Health HIV/AIDS Surveillance System
HIV/AIDS Perinatal Surveillance 2012 Minnesota Department of Health HIV/AIDS Surveillance System Background This slide set describes births to HIV-infected women in Minnesota by person, place, and time.
HIV/AIDS Perinatal Surveillance, HIV/AIDS Surveillance System STD/HIV/TB Section, Epidemiology and Surveillance Unit
HIV/AIDS Perinatal Surveillance, 2016 HIV/AIDS Surveillance System STD/HIV/TB Section, Epidemiology and Surveillance Unit Background (1/2) This slide set describes births to HIV-positive women in Minnesota
Sexually Transmitted Disease (STD) Surveillance Report, 2017
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Sexually Transmitted
Minneapolis/St. Paul, Minnesota Drug Abuse Trends: January 2014 Update
Minneapolis/St. Paul, Minnesota Drug Abuse Trends: January 2014 Update Carol Falkowski Drug Abuse Dialogues ABSTRACT Heroin and other opiate addiction continued to escalate in the Twin Cities in 2013.
SCOPE OF HIV/AIDS IN MINNESOTA
SCOPE OF HIV/AIDS IN MINNESOTA National Perspective Compared to the rest of the nation, Minnesota is considered to be a low- to-moderate HIV/AIDS incidence state. In 2013 (the most recent year for which
Opioid Use and Other Trends
Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current
Drug Abuse Trends Minneapolis/St. Paul, Minnesota
Drug Abuse Trends Minneapolis/St. Paul, Minnesota January 28 Carol Falkowski Chemical Health Division Minnesota Department of Human Services Numerous indicators of methamphetamine (meth) abuse, particularly
Minneapolis Department of Health and Family Support HIV Surveillance
Rate per 1, persons 2 21 22 23 24 25 26 27 28 29 21 Rate per 1, persons Minneapolis Department of Health and Family Support HIV Surveillance Research Brief, September 212 Human immunodeficiency virus (HIV)
MARY GRANDY TRAINING COORDINATOR MINNESOTA DEPARTMENT OF HUMAN SERVICES BECCA STICKNEY SENIOR COMMUNITY EDUCATOR MINNESOTA AIDS PROJECT
HIV/AIDS Minimum Standards Education MARY GRANDY TRAINING COORDINATOR MINNESOTA DEPARTMENT OF HUMAN SERVICES BECCA STICKNEY SENIOR COMMUNITY EDUCATOR MINNESOTA AIDS PROJECT Presentation Content HIV and
The Epidemiology of Tuberculosis in Minnesota,
The Epidemiology of Tuberculosis in Minnesota, 2011 2015 Minnesota Department of Health Tuberculosis Prevention and Control Program (651) 201-5414 Tuberculosis surveillance data for Minnesota are available
Poisoning Data for HIV/HCV Prevention Injury and Violence Prevention Unit
Channeling John Snow: Poisoning Data for HIV/HCV Prevention Injury and Violence Prevention Unit HIV Outbreak in Southeastern Indiana Community Outbreak of HIV in Rural Indiana Early 2015, investigation
Drug Abuse Trends Minneapolis/St. Paul, Minnesota
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Drug Abuse Trends Minneapolis/St.
Targeted Outreach & Other Strategies for Increasing HCV Testing
Targeted Outreach & Other Strategies for Increasing HCV Testing Working in Settings that Serve High-Risk Populations Webcast 2.4 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department
HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview
HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview Prepared by The Henry J. Kaiser Family Foundation for Southern States Summit
who use drugs in order to assist them in reducing harm while in the cycle of addiction
August 16, 2016 } Accepts that illicit drug use is part of our world, and chooses to minimize its harmful effects rather than ignore or condemn them } Calls for the provision of services to people who
What is injection drug use?
What is injection drug use? Essential Standards 7.ATOD.1 Understand the health risks associated with alcohol, tobacco, and other drug use. Clarifying Objectives 7.ATOD.1.2 - Explain health risks resulting
HIV/AIDS Surveillance Technical Notes
HIV/AIDS Surveillance Technical Notes Surveillance of HIV/AIDS The Minnesota Department of Health (MDH) collects case reports of HIV infection and AIDS diagnoses through a passive and active HIV/AIDS surveillance
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and
Opioid Deaths Quadruple Since 1999
THE COUNCIL OF STATE GOVERNMENTS CAPITOL RESEARCH AUGUST 2017 HEALTH POLICY Opioid Deaths Quadruple Since 1999 Since 1999, the number of overdose deaths involving opioids (including prescription opioids
Harm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction
Harm Reduction Dennis Radloff Human Services Program Coordinator Substance Abuse Services Topics for Today Overview of harm reduction Sterile syringe access programs Preventing fatal opioid overdoses Working
SULLIVAN COUNTY Drug Abuse Prevention Task Force
SULLIVAN COUNTY Drug Abuse Prevention Task Force Joseph A. Todora LMSW, Commissioner Sullivan County Division of Health ans Family Servies 17 Community Lane Liberty, NY 12754 MISSION: The mission of the
What is the strategy?
What is the strategy? Multi-pronged approaches to reducing the health consequences of opioid use, New York City Northeast Epidemiology Conference Public health approach Track drug use and associated health
Prescription Drug Abuse Task Force Rx Report Card
San Diego County Prescription Drug Abuse Task Force 2016 Rx Report Card October 2016 Key Measures of Prescription Drug and Heroin Problems in San Diego County. Visit www.sandiegorxabusetaskforce.org for
OPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know
OPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know WHAT S NEW UPDATE CUMBERLAND, MD Renata J. Henry, M.Ed. Director, Central East ATTC March 16, 2016 Behavioral Health is Essential to Health
Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin
Public Health Nurses, Hepatitis C, Injection Drug Use and Heroin Sheila Guilfoyle Viral Hepatitis Prevention Coordinator Division of Public Health Wisconsin Department of Health Services Wisconsin Public
National HIV Behavioral Surveillance Portland, Oregon
National HIV Behavioral Surveillance Portland, Oregon Tim W. Menza, MD, PhD Medical Director HIV/STD/TB Section Oregon Health Authority timothy.w.menza@state.or.us National HIV Behavioral Surveillance
Supplement to HIV and AIDS Surveillance (SHAS)
Supplement to HIV and AIDS Surveillance (SHAS) Introduction SHAS was a CDC-funded project designed to provide an in depth description of people diagnosed with HIV/AIDS in MN, including information about
September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201
September 1, 2017 The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 Dear Secretary Price: The National Association of County
Public Health Federal Funding Request to Address the Opioid Epidemic
Public Health Federal Funding Request to Address the Opioid Epidemic On December 4, 2017, in response to the President s recent declaration of the opioid epidemic as a public health emergency and the final
HIV Viral Suppression, 37 States and the District of Columbia, 2014
DOI 10.1007/s10900-017-0427-3 ORIGINAL PAPER HIV Viral Suppression, 37 States and the District of Columbia, 2014 Kristen L. Hess 1 H. Irene Hall 1 Published online: 18 September 2017 Springer Science+Business
Hepatitis B Virus and the Opioid Crisis
Hepatitis B Virus and the Opioid Crisis Alice Asher, RN, Ph.D. Epidemiology and Surveillance Branch Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers
Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis
Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and
The Syndemics of HIV, Hepatitis, and Overdose
The Syndemics of HIV, Hepatitis, and Overdose Sara Zeigler Associate Director for Policy Office of Policy, Planning and Partnerships (proposed) Centers for Disease Control and Prevention National Center
HIV and AIDS in the United States
HIV and AIDS in the United States A Picture of Today s Epidemic More than 20 years into the AIDS epidemic, HIV continues to exact a tremendous toll in the United States. Recent data indicate that African
Hawai i to Zero. Timothy McCormick Harm Reduction Services Branch Hawai i Department of Health. January 16, 2018
HIV Prevention Efforts in Hawai i Hawai i to Zero Timothy McCormick Harm Reduction Services Branch Hawai i Department of Health January 16, 2018 People living with HIV who take HIV medicine as prescribed
Minnesota HIV Strategy: A Comprehensive Plan to End HIV/AIDS
Minnesota HIV Strategy: A Comprehensive Plan to End HIV/AIDS 02/09/2018 Minnesota HIV Strategy: A Comprehensive Plan to End HIV/AIDS Minnesota Department of Health Infectious Disease Epidemiology, Prevention
Sexually Transmitted Disease (STD) Surveillance Report, 2016
Sexually Transmitted Disease (STD) Surveillance Report, 2016 Minnesota Department of Health STD Surveillance System STD/HIV/TB Section Introduction Under Minnesota law, physicians and laboratories must
Population Percent C.I. All Hennepin County adults aged 18 and older 12.1% ± 1.2
Overview ` Why Is This Indicator Important? Tobacco use remains the single most preventable cause of disease, disability and death in the United States. How Are We Doing? In the past decade, smoking rate
Table 1. Number I and Rate II (per 100,000) of Persons Living with HIV (non-aids) and AIDS by Residence, Age, and Gender -- Minnesota, 2013
Table 1. Number I and Rate II (per 100,000) of Persons Living with HIV (non-) and by Residence, Age, and Gender -- Minnesota, 2013 Group HIV (non-) HIV/ Cases % Cases % Cases % Prevalence Rate Residence
Pennsylvania Prescription Drug Monitoring Program Trends,
DEA Intelligence Report Brief DEA-PHL-DIR-006-17 Pennsylvania Prescription Drug Monitoring Program Trends, 2014-2015 December 2016 1 Executive Summary The abuse and diversion of pharmaceutical drugs, particularly
OVERVIEW. NCHRC Harm Reduction Pills Ingestion to Smoking/Injecting Harm Reduction Legislation, Services and Advocacy Ban the Box/Fair Hiring LEAD Q+A
OVERVIEW NCHRC Harm Reduction Pills Ingestion to Smoking/Injecting Harm Reduction Legislation, Services and Advocacy Ban the Box/Fair Hiring LEAD Q+A North Carolina Harm Reduction Coalition (NCHRC) is
5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives
Persistent Challenge of HIV Transmission Control in Injection Drug Use: The Indiana Outbreak John T. Brooks, MD Senior Medical Advisor, Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral
WASHINGTON STATE COMMUNICABLE DISEASES OF PUBLIC HEALTH SIGNIFICANCE FOR THE CIVIL SURGEON
WASHINGTON STATE COMMUNICABLE DISEASES OF PUBLIC HEALTH SIGNIFICANCE FOR THE CIVIL SURGEON SCOTT LINDQUIST MD MPH WASHINGTON STATE DEPARTMENT OF HEALTH STATE EPIDEMIOLOGIST FOR COMMUNICABLE DISEASES FOREIGN-BORN
Minnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending January
The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015
The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap
COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms
COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, 2018 2 Objectives: qreview names of different types of opioids qidentify the signs and symptoms
Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING
Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING Opioid Epidemic Prescription Opiods Can be prescribed by doctors to treat moderate to severe pain, but can also have serious risks and side
King County (Seattle Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018
King County (Seattle Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018 November 2018 NDEWS Coordinating Center National Drug Early Warning System (NDEWS) www.ndews.org ndews@umd.edu
Drug Overdose Deaths St. Louis County, Missouri
Drug Overdose Deaths St. Louis County, Missouri An overdose occurs when an excess and dangerous amount of a substance, such as alcohol, over thecounter medicine, prescription drugs, or illicit drug is
Minnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending February
Minnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending April
Good Samaritan. State with this law in place: New Mexico, Washington, New York, Connecticut, Illinois (to be enforced June 1, 2012)
Good Samaritan Immunity Laws that provide protection from prosecution for calling 911 if seeking medical attention for self or another experiencing an overdose The US Conference of Mayors 2008 unanimously
Minnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending December
Cirrhosis and Liver Cancer Mortality in the United States : An Observational Study Supplementary Material
Cirrhosis and Liver Cancer Mortality in the United States 1999-2016: An Observational Study Supplementary Material Elliot B. Tapper MD (1,2) and Neehar D Parikh MD MS (1,2) 1. Division of Gastroenterology
Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018
Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018 Overview Background to injecting drug use Overview of harm reduction Data on Hepatitis Summary of services provided by
HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge
HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe
Minnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
Ingham County Opioid Surveillance
Medical Examiner Source: Ingham County Medical Examiner, *Data is current as of Jul 9, 2018 42 total drug-related deaths (Table 1 & Fig. 1) 34 deaths were opioid-related 30 opioid-related deaths were Ingham
State and Local Policies Regarding IDUs' Access to Sterile Syringes December 2005
State and Local Policies Regarding IDUs' Access to Sterile Syringes December 2005 In many cities and states, laws and regulations make possession of syringes a crime and limit IDUs' ability to legally
2006 Minnesota Sexually Transmitted Disease Statistics
2006 Minnesota Sexually Transmitted Disease Statistics Minnesota Department of Health, STD and HIV Section For more information, contact: (651) 201-5414 Overall Summary: The 2006 Sexually Transmitted Disease
Drug Overdose Summary- Mendocino County, CA. Mendocino County Health & Human Services Agency Healthy People, Healthy Communities
Drug Overdose Summary- Mendocino County, CA Mendocino County Health & Human Services Agency Healthy People, Healthy Communities Injury Fact Sheet: Mendocino County Drug Overdose Summary Tables Deaths 2002
Addressing Substance Abuse To Improve Well-Being in Child Welfare Systems Current Trends, Continuing Challenges
Addressing Substance Abuse To Improve Well-Being in Child Welfare Systems Current Trends, Continuing Challenges Three Branch Institute on Child Well-Being July 1, 2014 Sid Gardner, MPA Drugs of the Decades
Opioids: Public Health Crisis Local Solutions: National Epidemic
Opioids: Public Health Crisis Local Solutions: National Epidemic Nancy McGraw, LCSW, MBA Public Health Director Sullivan County Public Health Services 50 Community Lane Liberty, NY 12754 Luis Alvarez,
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides
HIV in Prisons,
U.S. Department of Justice Office of Justice Programs Bureau of Justice Statistics Bureau of Justice Statistics BULLETIN HIV in Prisons, 2007-08 Laura M. Maruschak BJS Statistician Randy Beavers, BJS Intern
TOWARD A REAL-TIME DRUG OVERDOSE MONITORING SYSTEM
TOWARD A REAL-TIME DRUG OVERDOSE MONITORING SYSTEM Using Locally Available Data Richard Harruff, MD, PhD Chief Medical Examiner Julia Hood, PhD, MPH Epidemiologist Goals for Today s Presentation 1. Make
Shannon Whitman Program Administrator Advancing Use of the MN PMP
Shannon Whitman Program Administrator Advancing Use of the MN PMP TODAY S OBJECTIVE What is a PMP/PDMP, why do we need one? What is the national status of PMPs? Minnesota s intent of the PMP What does
Drug Abuse Trends in Minneapolis/St. Paul, Minnesota: June 2012
Drug Abuse Trends in Minneapolis/St. Paul, Minnesota: June 2012 Carol L. Falkowski Drug Abuse Strategy Officer Minnesota Department of Human Services June 2012 ABSTRACT Escalating trends regarding the
Systematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E.
Systematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E. Buttram, PhD Nova Southeastern University Center for Applied Research on
Drug Epidemics: Things You Need to Know. Prof. Carl L. Hart Columbia University. drcarlhart.com
Drug Epidemics: Things You Need to Know Prof. Carl L. Hart Columbia University drcarlhart.com 10 MA vs. $20 Choice (max =10) 8 6 4 2 drug users can and do behave rationally 0 Drug Money Reinforcer Things
1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0
1 HB37 2 188862-1 3 By Representative Williams (JD) 4 RFD: Health 5 First Read: 09-JAN-18 6 PFD: 11/28/2017 Page 0 1 188862-1:n:11/16/2017:PMG/tj LSA2017-3516 2 3 4 5 6 7 8 SYNOPSIS: This bill would establish
Opioid Abuse. in Rural Minnesota. County Farm Bureau Resource Guide
Opioid Abuse in Rural Minnesota County Farm Bureau Resource Guide STATS MINNESOTA 80 100 of every Prescriptions nationwide are written for an opiate. 395 Number of opioidrelated deaths in MN in 2016. 41,558
Opioid Task Force Kick-Off Meeting. February 29, 2016
Opioid Task Force Kick-Off Meeting February 29, 2016 Scope of the Opioid Problem and Data Review Olivia Kasirye, MD, MS County Public Health Officer OVERVIEW The Opioid Epidemic Opioid Task Force Development
Minnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending October
HARM REDUCTION & TREATMENT. Devin Reaves MSW
HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that
Hepatitis A and B outbreaks in Massachusetts,
Hepatitis A and B outbreaks in Massachusetts, 2017-2018 Shauna Onofrey, MPH Viral Hepatitis Surveillance Coordinator Massachusetts Department of Public Health Massachusetts Background Population: 6.86
Opioid Prescription and Illicit Drug Overdoses: On the Rise
Opioid Prescription and Illicit Drug Overdoses: On the Rise Cindy Haynes, MSA-PA, CHES Chronic Pain Program Coordinator Northern Piedmont Community Care Duke Division of Community Health Objectives Define
Understanding the Opiate Epidemic
Understanding the Opiate Epidemic An opiate is a narcotic analgesic that depresses the central nervous system. Natural opiates are derived from the poppy plant. Synthetic opiates are manufactured drugs
Drug Abuse Trends in Minneapolis/St. Paul, Minnesota: June 2012
Drug Abuse Trends in Minneapolis/St. Paul, Minnesota: June 2012 Carol L. Falkowski Drug Abuse Strategy Officer Minnesota Department of Human Services ABSTRACT The escalating abuse of heroin and prescription
Hepatitis Case Investigation
* indicates required fields Does patient also have: Hepatitis Case Investigation West Virginia Electronic Disease Surveillance System Division of Surveillance and Disease Control Infectious Disease Epidemiology
Advocating for Syringe Exchange Programs
Advocating for Syringe Exchange Programs AMERICAN BAR ASSOCIATION AIDS COORDINATING COMMITTEE HIV Law & Practice Conference 2018 New Orleans, LA February 22, 2018 William McColl Vice President for Policy
North Carolina, like the rest of the nation, is experiencing
ORIGINAL ARTICLE Overdose Deaths and Acute Hepatitis Infections among American Indians in North Carolina Mary E. Cox, Nicole Dzialowy, Lillie Armstrong, Scott Proescholdbell background Like the rest of
Hospitalizations for Infective Endocarditis Among Individuals Using Opioids in Philadelphia,
Hospitalizations for Infective Endocarditis Among Individuals Using Opioids in Philadelphia, 2008-2015 Lia N. Pizzicato, MPH CSTE Applied Epidemiology Fellow Philadelphia Department of Public Health Northeast
Epidemiology of HIV Among Women in Florida, Reported through 2014
To protect, promote and improve the health of all people in Florida through integrated state, county, and community efforts. Created: 12/4/14 Revision: 1/27/15 Epidemiology of HIV Among Women in Florida,
Washington State s Overdose Epidemic
Caleb Banta-Green PhD MPH MSW Senior Research Scientist- Alcohol and Drug Abuse Institute Affiliate Associate Professor- School of Public Health Affiliate Faculty- Harborview Injury Prevention & Research
But like others, we were initially fighting pill mills. Orange County worked to outlaw them and to provide resources for breaking opioid addiction.
U.S. House of Representatives Committee on Oversight and Government Reform Witness Testimony by Orange County, Florida Mayor Teresa Jacobs FINAL Remarks as Prepared 668 words (5 minutes) Tuesday, March
Sexually Transmitted Disease (STD) Surveillance Report, 2012
Sexually Transmitted Disease (STD) Surveillance Report, 2012 Minnesota Department of Health STD Surveillance System www.health.state.mn.us/std Introduction Under Minnesota law, physicians and laboratories
Drug Abuse Trends in Minneapolis/St. Paul, Minnesota: June 2013
Drug Abuse Trends in Minneapolis/St. Paul, Minnesota: June 2013 Carol Falkowski Drug Abuse Dialogues ABSTRACT Heroin and prescription opiates dominated the drug abuse situation in the Minneapolis/St. Paul
NDEWS Sentinel Community Site Advance Report 2016: Selected Findings for Heroin, Fentanyl, and Methamphetamine
NDEWS Sentinel Community Site Advance Report 2016: Selected Findings for Heroin, Fentanyl, and Methamphetamine Heroin, fentanyl, and 12 NDEWS Sentinel Community Sites 2016 methamphetamine are drugs of
Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next
Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery Drug Policy, Harm Reduction, and What s Next The start or lack thereof of Drug Policy in the United States The Harrison Narcotics
Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary
Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon 2016 Executive Summary 20.8 million people in the United States have a substance use disorder (not limited to opioids), equivalent
Opioid Withdrawal, Opioid Substitution Treatment, and HIV Infection
Opioid Withdrawal, Opioid Substitution Treatment, and HIV Infection R. Douglas Bruce, MD, MA, MS Associate Clinical Professor of Medicine Yale University Chief of Medicine Cornell Scott-Hill Health Center
Minnesota Influenza Geographic Spread
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
Weekly Influenza & Respiratory Illness Activity Report
Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March
NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND
NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND Law Enforcement and Public Safety!!!!!!! Ariel Engelman NOPE-RI Coordinator 1 Opioids and Overdose in Rhode Island 2 Opioids and Overdose
Summit County Public Health
Page 1 Death and Life Expectancy Summit County Public Health Population Health Vital Statistics Brief: VOLUME 1: DEATH AND LIFE EXPECTANCY Summit County Public Health Population Health Division 1867 W.
OPIOIDS IN JACKSON COUNTY A PUBLIC HEALTH PERSPECTIVE OPIOID AWARENESS COUNTY LEADERSHIP FORUM SHELLEY CARRAWAY, HEALTH DIRECTOR DATE
OPIOIDS IN JACKSON COUNTY A PUBLIC HEALTH PERSPECTIVE OPIOID AWARENESS COUNTY LEADERSHIP FORUM SHELLEY CARRAWAY, HEALTH DIRECTOR DATE LOCAL HEALTH DIRECTOR REGIONS For counties with low counts, regional